Coloured dots | Gradea | Test | Summary of the recommendations |
---|---|---|---|
Red | D | Pelvic ultrasound | Not recommended as routine screening for ovarian cancer. |
Red | D | Cancer antigen 19-9 | Not recommended as routine screening for pancreatic cancer. |
Red | D | Rest electrocardiography | Not recommended in asymptomatic adults at low risk for coronary heart disease events. |
Red | D | Exercise electrocardiography | Not recommended in asymptomatic adults at low risk for coronary heart disease events. |
Red | D | Carotid artery ultrasound | Not recommended as screening for asymptomatic carotid artery stenosis in the general adult population. |
Red | D | Spirometry | Not recommended as screening adults for chronic obstructive pulmonary disease. |
Red | D | Hepatitis B surface antigen | Not recommended as routine screening. |
Red | D | Hepatitis C antibodies | Not recommended as routine screening. |
Yellow | I | Triglycerides | There is currently insufficient evidence of the benefit of including triglycerides as a part of the initial tests used to screen routinely for dyslipidemia. |
Yellow | I | Prostate-specific antigen | The evidence is insufficient to recommend for or against routine screening for prostate cancer in men younger than 75. |
Yellow | I | Lung computed tomography | The evidence is insufficient to recommend for or against routine screening for lung cancer. |
Yellow | I | Lung X-ray | The evidence is insufficient to recommend for or against routine screening for lung cancer. |
Yellow | I | Thyroid-stimulating hormone | The evidence is insufficient to recommend for or against routine screening. |
Green | B | Glucose | Screening for type 2 diabetes recommended in asymptomatic adults with sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg. |
Green | A/B | Total cholesterol | Recommended every 5 years, for men aged 35 and older and women 45 and older if they are at increased risk for coronary heart disease. At younger ages if they are at increased risk for coronary heart disease. |
Green | B | Mammography | Biennial screening recommended for women aged 50 to 74 years. |
Green | A | Cervicovaginal cytology | Every 3 years screening recommended for women who have cervix, 21 to 65 years old. |
Green | A | Faecal occult blood test | Recommended annually as a possible method of screening for colorectal cancer, 50 to 75 years. |
Green | A | Colonoscopy | Recommended every 10 years as a possible method of screening for colorectal cancer, 50 to 75 years. |
Green | A | Flexible sigmoidoscopy | Recommended every 5 years as a possible method of screening for colorectal cancer, 50 to 75 years. |
Green | A/B | HDL cholesterol | Recommended every 5 years, for men aged 35 and older and women 45 and older if they are at increased risk for coronary heart disease. At younger ages if they are at increased risk for coronary heart disease. |
Green | B | DXAb of the hip and lumbar spine | Screening recommended for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old. |
Green | A | Venereal Disease Research Laboratory | Recommended for persons at increased risk for syphilis infection. |